• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

An exploratory biomarker analyses on predictive factors of efficacy for personalized therapy for salivary duct carcinoma

Research Project

Project/Area Number 18K09386
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56050:Otorhinolaryngology-related
Research InstitutionInternational University of Health and Welfare

Principal Investigator

TADA Yuichiro  国際医療福祉大学, 医学部, 准教授 (70292430)

Co-Investigator(Kenkyū-buntansha) 長尾 俊孝  東京医科大学, 医学部, 主任教授 (90276709)
赤澤 宏平  新潟大学, 医歯学総合病院, 教授 (10175771)
伏見 千宙  国際医療福祉大学, 大学病院, 講師 (20623531)
平井 秀明  東京医科大学, 医学部, 助教 (00770744)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords唾液腺導管癌 / HER2 / アンドロゲン受容体 / トラスツズマブ / アンドロゲン遮断療法 / ビカルタミド / リュープロレリン / 治療効果予測因子 / リュープリン / 治療効果予測 / 唾液腺癌 / 予後予測因子 / 個別化治療
Outline of Final Research Achievements

The latest edition of the NCCN Guidelines recommends two drug therapies, anti-androgen therapy or anti-HER2 therapy, for recurrent and metastatic Salivary duct carcinoma (SDC), but the method of selection has not yet been established. In this study, we investigated 134 patients treated with anti-androgen therapy and 111 patients treated with anti-HER2 therapy. In patients treated with CAB, PS, sex, inflammatory markers, Ki-67, PTEN, and adipophilin were significantly correlated with prognosis. In patients treated with anti-HER2 therapy, PTEN, CRP level, and mGPS were significantly correlated with prognosis.

Academic Significance and Societal Importance of the Research Achievements

SDCは遠隔転移が死因の最多を占める高悪性度癌である。我々は世界に先駆けてアンドロゲン受容体(AR)陽性例に対するリュープリン・ビカルタミド併用療法と、HER2陽性例に対するトラスツズマブ・ドセタキセル併用療法の2つの前向き試験を開始し、本研究期間中に、結果を論文発表した。この結果、アンドロゲン遮断療法は非常に安全な治療である一方、奏効率は抗HER2療法が優れていることが判明していた。2つの治療法をどのように選択していくべきか、結論は得られなかったが、予後と有意な関連を認めた治療効果予測因子に、それぞれの治療の特徴を加味して2つの治療法を選択していくことが有用と考えれらた。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (35 results)

All 2020 2019 2018 2017 Other

All Int'l Joint Research (2 results) Journal Article (16 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 14 results,  Open Access: 11 results) Presentation (10 results) (of which Int'l Joint Research: 4 results,  Invited: 3 results) Book (3 results) Remarks (4 results)

  • [Int'l Joint Research] Radboud University Medical Center(オランダ)

    • Related Report
      2020 Annual Research Report
  • [Int'l Joint Research] Radboud University Nijmegen(オランダ)

    • Related Report
      2019 Research-status Report
  • [Journal Article] Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma2020

    • Author(s)
      Nakaguro Masato、Sato Yukiko、Tada Yuichiro、Kawakita Daisuke、Nagao Toshitaka et al.
    • Journal Title

      The American Journal of Surgical Pathology

      Volume: 44 Issue: 4 Pages: 526-535

    • DOI

      10.1097/pas.0000000000001413

    • Related Report
      2020 Annual Research Report 2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma.2020

    • Author(s)
      Hirai H、Tada Y、Nakaguro M、Kawakita D、Sato Y、Shimura T、Tsukahara K、Kano S、Ozawa H、Okami K、Sato Y、Fushimi C、Shimizu A、Okamoto I、Takase S、Okada T、Sato H、Imanishi Y、Otsuka K、Watanabe Y、Sakai A、Ebisumoto K、Togashi T、Ueki Y、Ota H、Saigusa N、Takahashi H、Ando M、Urano M、Hanazawa T、Nagao T
    • Journal Title

      Virchows Arch

      Volume: X Issue: 2 Pages: 291-299

    • DOI

      10.1007/s00428-020-02777-w

    • Related Report
      2020 Annual Research Report 2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment2020

    • Author(s)
      Nakaguro Masato、Tada Yuichiro、Faquin William C.、Sadow Peter M.、Wirth Lori J.、Nagao Toshitaka
    • Journal Title

      Cancer Cytopathology

      Volume: - Issue: 10 Pages: 693-703

    • DOI

      10.1002/cncy.22288

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review2020

    • Author(s)
      Uijen M.J.M.、Lassche G.、van Engen-van Grunsven A.C.H.、Tada Y.、Verhaegh G.W.、Schalken J.A.、Driessen C.M.L.、van Herpen C.M.L.
    • Journal Title

      Cancer Treatment Reviews

      Volume: 89 Pages: 102069-102069

    • DOI

      10.1016/j.ctrv.2020.102069

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma2020

    • Author(s)
      Niwa Kazutomo、Kawakita Daisuke、Nagao Toshitaka、Takahashi Hideaki、Saotome Takashi、Okazaki Masashi、Yamazaki Keisuke、Okamoto Isaku、Hirai Hideaki、Saigusa Natsuki、Fushimi Chihiro、Okazaki Shin-ichi、Matsui Hirooki、Iwaki Sho、Matsuki Takashi、Tsukahara Kiyoaki、Oridate Nobuhiko、Tada Yuichiro
    • Journal Title

      Scientific Reports

      Volume: 10 Issue: 1 Pages: 16988-16988

    • DOI

      10.1038/s41598-020-73965-6

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] 特集 唾液腺腫瘍の診療最前線 《治療》 薬物療法2020

    • Author(s)
      多田 雄一郎
    • Journal Title

      耳鼻咽喉科・頭頸部外科

      Volume: 92 Pages: 730-738

    • Related Report
      2020 Annual Research Report
    • Open Access
  • [Journal Article] Central pathology review of salivary gland adenoid cystic carcinoma2020

    • Author(s)
      Ueda K、Murase T、Nagao T、Kusafuka K、Urano M、Yamamoto H、Nakaguro M、Taguchi K、Masaki A、Hirai H、Kawakita D、Tsukahara K、Hato N、Nagao T、Fujimoto Y、Sakurai K、Hanai N、Kano S、Onitsuka T、Okami K、Nibu K、Tada Y、Kawata R、Inagaki H
    • Journal Title

      Head & Neck

      Volume: X Issue: 8 Pages: 1721-1727

    • DOI

      10.1002/hed.26081

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma2020

    • Author(s)
      Morita Maki、Murase Takayuki、Okumura Yoshihide、Ueda Kaori、Sakamoto Yuma、Masaki Ayako、Kawakita Daisuke、Tada Yuichiro、Nibu Ken‐Ichi、Shibuya Yasuyuki、Inagaki Hiroshi
    • Journal Title

      Histopathology

      Volume: X Issue: 7 Pages: 1013-1022

    • DOI

      10.1111/his.14100

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Classification of tumors by imaging diagnosis and preoperative fine‐needle aspiration cytology in 120 patients with tumors in the parapharyngeal space2019

    • Author(s)
      Matsuki Takashi、Miura Kouki、Tada Yuichiro、Masubuchi Tatsuo、Fushimi Chihiro、Kanno Chihiro、Takahashi Hideaki、Kamata Shinetsu、Okamoto Isaku、Miyamoto Shunsuke、Yamashita Taku
    • Journal Title

      Head & Neck

      Volume: 41 Issue: 5 Pages: 1277-1281

    • DOI

      10.1002/hed.25552

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum2019

    • Author(s)
      Urano Makoto、Nakaguro Masato、Yamamoto Yoshinari、Hirai Hideaki、Tanigawa Maki、Saigusa Natsuki、Shimizu Akira、Tsukahara Kiyoaki、Tada Yuichiro、Sakurai Kouhei、Isomura Madoka、Okumura Yuki、Yamaguchi Hiroshi、Matsubayashi Jun、Nagao Toshitaka
    • Journal Title

      The American Journal of Surgical Pathology

      Volume: 印刷中 Issue: 7 Pages: 984-994

    • DOI

      10.1097/pas.0000000000001258

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study2019

    • Author(s)
      OKADA TAKURO、SAOTOME TAKASHI、NAGAO TOSHITAKA、MASUBUCHI TATSUO、FUSHIMI CHIHIRO、MATSUKI TAKASHI、TAKAHASHI HIDEAKI、MIURA KOUKI、TSUKAHARA KIYOAKI、TADA YUICHIRO
    • Journal Title

      In Vivo

      Volume: 33 Issue: 3 Pages: 843-853

    • DOI

      10.21873/invivo.11549

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm2019

    • Author(s)
      Nakaguro Masato、Urano Makoto、Ogawa Ikuko、Hirai Hideaki、Yamamoto Yoshinari、Yamaguchi Hiroshi、Tanigawa Maki、Matsubayashi Jun、Hirano Hiroshi、Shibahara Junji、Tada Yuichiro、Tsuzuki Toyonori、Okada Yasuo、Sato Yuichiro、Ikeda Kenichiro、Sukeda Aoi、Honda Yumi、Mikami Yoshiki、Nagao Toshitaka
    • Journal Title

      Histopathology

      Volume: 76 Issue: 3 Pages: 411-422

    • DOI

      10.1111/his.13990

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] 唾液腺癌に対する薬物療法2019

    • Author(s)
      多田雄一郎
    • Journal Title

      日本唾液腺学会誌

      Volume: 60 Pages: 31-45

    • Related Report
      2019 Research-status Report
  • [Journal Article] Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2 Positive Salivary Duct Carcinoma2019

    • Author(s)
      Takahashi Hideaki、Tada Yuichiro、Saotome Takashi、Akazawa Kohei、Ojiri Hiroya、Fushimi Chihiro、Masubuchi Tatsuo、Matsuki Takashi、Tani Kaori、Osamura Robert Y.、Hirai Hideaki、Yamada Shuhei、Kawakita Daisuke、Miura Kouki、Kamata Shin-etsu、Nagao Toshitaka
    • Journal Title

      Journal of Clinical Oncology

      Volume: 37 Issue: 2 Pages: 125-134

    • DOI

      10.1200/jco.18.00545

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases2018

    • Author(s)
      Urano Makoto、Hirai Hideaki、Tada Yuichiro、Otsuka Kuninori、Watanabe Yoshihiro、Sakai Akihiro、Ebisumoto Koji、Togashi Takafumi、Ueki Yushi、Ota Hisayuki、Sato Yukiko、Saigusa Natsuki、Nakaguro Masato、Hanazawa Toyoyuki、Nagao Toshitaka
    • Journal Title

      Histopathology

      Volume: 73 Issue: 6 Pages: 943-952

    • DOI

      10.1111/his.13706

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma2017

    • Author(s)
      Fushimi C、Tada Y、Takahashi H、Nagao T、Ojiri H、Masubuchi T、Matsuki T、Miura K、Kawakita D、Hirai H、Hoshino E、Kamata S、Saotome T
    • Journal Title

      Annals of Oncology

      Volume: 29 Issue: 4 Pages: 979-984

    • DOI

      10.1093/annonc/mdx771

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 液腺細胞診ミラノシステムの運用経験と有用性-各職種の立場から- 唾液腺細胞診ミラノシステムの有用性 臨床的立場から2020

    • Author(s)
      多田雄一郎
    • Organizer
      日本臨床細胞学会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] Combined androgen blockade in patients with advanced androgen receptor positive salivary gland carcinoma: Exploratory biomarker analyses2019

    • Author(s)
      C. Fushimi、D. Kawakita、H. Takahashi、T. Nagao、H. Hirai、N. Saigusa、T. Masubuchi、T. Matsuki、T. Okada、D. Baba、K. Miura、T. Saotome、Y. Tada
    • Organizer
      ESMO Congress 2019
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Trastuzumab plus docetaxel in patients with advanced HER2 positive salivary duct carcinoma: Exploratory biomarker analyses2019

    • Author(s)
      H. Takahashi、D. Kawakita、C. Fushimi、T. Nagao、H. Hirai、N. Saigusa、T. Masubuchi、T. Matsuki、T. Okada、D. Baba、K. Miura、T. Saotome、Y. Tada
    • Organizer
      ESMO Congress 2019
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Frequent HRAS Mutations Characterize, and Help Overcome the Diagnostic Dilemma Associated with the Histological Diversity of Epithelial Myoepithelial Carcinoma2019

    • Author(s)
      Makoto Urano、Masato Nakaguro、Hideaki Hirai、Maki Tanigawa、Kiyoaki Tsukahara、Yuichiro Tada、Toshitaka Nagao
    • Organizer
      USCAP 2019 Annual Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] 唾液腺導管癌の新たな治療戦略、 テーラーメイド医療の現状2019

    • Author(s)
      多田 雄一郎
    • Organizer
      第108回日本病理学会総会
    • Related Report
      2019 Research-status Report
    • Invited
  • [Presentation] 唾液腺導管癌における脂質関連蛋白発現の臨床病理学的意義2019

    • Author(s)
      平井秀明、多田雄一郎、中黒匡人、川北大介、佐藤由紀子、志村智隆、塚原清彰、加納里志、小澤宏之、大上研二、佐藤雄一郎、伏見千宙、清水顕、高瀬総一郎、岡田拓朗、佐藤宏樹、今西順久、大塚邦憲、渡部佳弘、酒井昭博、戎本浩史、富樫孝文、植木雄志、太田久幸、三枝奈津季、高橋秀聡、安藤瑞生、浦野誠、花澤豊行、長尾俊孝
    • Organizer
      第64回日本唾液腺学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 唾液腺導管癌の頭頸部領域病変に対するトラスツズマブ・ドセタキセル併用化学療法後の放射線療法の検討2019

    • Author(s)
      伏見千宙、増淵達夫、岡田拓朗、馬場大輔、三浦弘規、五月女隆、長尾俊孝、多田雄一郎
    • Organizer
      臨床腫瘍学会
    • Related Report
      2019 Research-status Report
  • [Presentation] Novel approach for unresectable salivary duct carcinoma: Targeting HER2 and androgen receptor.2018

    • Author(s)
      Daisuke Kawakita, Yuichiro Tada, Chihiro Fushimi, Hideaki Takahashi, Tatsuo Masubuchi, Kouki Miura, Satoshi Kano, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Yuichiro Sato, Akira Shimizu, Yorihisa Imanishi, Toyoyuki Hanazawa, Mizuo Ando, Hideaki Hirai, Toshitaka Nagao
    • Organizer
      American Society of Clinical Oncology Annual meeting 2018
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Presentation] 耳下腺癌に対する新たな化学療法2018

    • Author(s)
      多田雄一郎
    • Organizer
      第63回日本唾液腺学会
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] 唾液腺導管癌における重要な治療標的分子の遺伝子変異と蛋白発現 その予後・組織発生との関連2018

    • Author(s)
      志村智隆、多田雄一郎
    • Organizer
      第119回日本耳鼻咽喉科学会総会
    • Related Report
      2018 Research-status Report
  • [Book] 唾液腺/口腔・歯原性腫瘍2019

    • Author(s)
      青笹克之、長尾俊孝、高田 隆
    • Total Pages
      400
    • Publisher
      中山書店
    • ISBN
      9784521742724
    • Related Report
      2019 Research-status Report
  • [Book] 唾液腺細胞診ミラノシステム2019

    • Author(s)
      樋口佳代子、浦野誠
    • Total Pages
      155
    • Publisher
      金芳堂
    • ISBN
      9784765317863
    • Related Report
      2019 Research-status Report
  • [Book] 医学のあゆみBOOKS耳鼻咽喉科診療の進歩40のエッセンス2018

    • Author(s)
      山岨達也
    • Total Pages
      216
    • Publisher
      医歯薬出版株式会社
    • ISBN
      9784263206799
    • Related Report
      2018 Research-status Report
  • [Remarks] 唾液腺腫瘍外来

    • URL

      https://mita.iuhw.ac.jp/clinic/toukeibu/suieki.html

    • Related Report
      2020 Annual Research Report
  • [Remarks] 唾液腺導管癌に対する新しい個別化薬物治療に関する後方視観察研究

    • URL

      http://mita.iuhw.ac.jp/clinic/toukeibu/pdf/kenkyu01.pdf

    • Related Report
      2019 Research-status Report
  • [Remarks] 日本人論文詳細(HER2陽性唾液腺導管癌に対するトラスツズマブ+ドセタキセル療法の第II相試験 )

    • URL

      https://www.usaco.co.jp/article/detail.html?ItemId=718&dispmid=610

    • Related Report
      2018 Research-status Report
  • [Remarks] 高悪性度唾液腺癌に対する新規個別化薬物療法の開発

    • URL

      http://mita.iuhw.ac.jp/pdf/topics/2018/20181226.pdf

    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi